Oncolytic Coxsackievirus type B3 (CVB3) was previously shown to induce cytopathic effects only in lung carcinoma with G12C K-Ras mutation and not to affect the viability of lung epithelial cells with wild-type K-Ras [43]. The gene discussed is KRAS; the disease is lung carcinoma.